Recognized Biomedical Research Leaders 2025

Clinically trained veterinarian with experience in gastroenterology, internal medicine, and emergency care. Veterinary physician-scientist specializing in clinical research, diagnostic development, and translational medicine in companion animals, supporting research initiatives in oncology and internal medicine. Skilled in clinical sample characterization and biobank operations, including medical record review of 4,000+ veterinary cases and collaboration with academic and clinical partners. Holds a PhD in Biomedical Sciences focused on cell biology and organoid technology with multiple pending patents, with experience in disease modeling and scientific publication. Regularly collaborates with senior leadership to align cross-functional teams and advance complex research initiatives, complemented by an MBA focused on strategy and project management.

I know someone who knows someone:)Current affiliate projects I'm working on- Connecting people who are interested in investing in international real estate (main focus : UK, Greece and Egypt) with pie.properties. Ask me about the free consulation session!- Connecting people who want to improve their productivity by beating digital distractions to Focusmate (Ask me to send you a free trial).

Shahadat Hussain, PhD, is a Research Associate in Division of Engineering at New York University in Abu Dhabi, UAE. Specializing in advanced materials science, he focuses on metamaterials, additive manufacturing (particularly laser powder bed fusion), triply periodic minimal surface (TPMS) lattices, and NiTi shape memory alloys for applications in aerospace, medical devices, and robotics. With a PhD in Materials Science and Technology, Shahadat combines computational design, experimental characterization, mechanical testing, and data science to tackle challenges like Ni evaporation, microstructural imperfections, and phase transformations in 3D-printed structures. His work advances tunable metamaterials with unique properties (e.g., negative refractive indices) and shape memory materials exhibiting superelasticity and recovery. Key publications include: 1. "Imperfections formation in thin layers of NiTi TPMS lattices" (Materials, 2022) 2. "Microstructural and surface analysis of NiTi TPMS lattice sections" (Journal of Manufacturing Processes, 2023) 3. "Phase Transformation Behavior of NiTi TPMS Lattices" (Journal of Materials Engineering and Performance, 2025) 4. Conference presentation at ASME IMECE 2022 on inhomogeneous microstructures Recent efforts feature bending analysis of single-phase metamaterial beams (communicated to Progress in Additive Manufacturing, 2026) and four-point flexural testing of interpenetrating phase composite metamaterials (2026). He collaborates with researchers, industry partners, and journals to push boundaries in rapid prototyping and innovative materials. Shahadat is passionate about sustainable technologies and multidisciplinary innovation. Visit his personal website for more details: www.shahadathussain.com. He maintains active profiles on LinkedIn, Google Scholar, ORCID, ResearchGate, and GitHub. Based in Abu Dhabi (PO Box 129188), he bridges theory and practical impact in cutting-edge engineering. Personal Website: www.shahadathussain.com

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Adrian Wadowski is the Brand Director at CamelWay, Europe's premier producer of functional camel milk. He is a leading voice on the therapeutic applications of alternative dairy, specifically for metabolic health (Type 1 & 2 Diabetes) and autoimmune support. Adrian specializes in the "Gut-Skin Axis", educating on how Lactoferrin and IgG can support recovery from Eczema and Psoriasis. He is also an advocate for Casomorphin-free (GFCF) diets to support neurodiversity and Autism therapy. He oversees EU-certified production using advanced low-temperature spray drying technology, ensuring the preservation of bioactive proteins often lost in standard processing.

I am a research scientist with expertise in machine learning, neuroimaging, and clinical data analysis. My work focuses on applying AI, signal processing, and multimodal data integration to EEG, MRI, and related biomedical data, with experience spanning academia, healthcare, and industry. I have developed machine learning and deep learning pipelines for neural decoding, clinical document processing, and predictive modeling, and I have published and presented research in computational neuroscience and medical AI.

As a Mechanical Engineer and Business Analyst, I thrive at the intersection of engineering innovation and strategic problem-solving. With experience in business development, market analysis, and process optimisation, I’ve delivered impactful results—whether driving market expansion or improving processes in manufacturing. Passionate about leveraging technology and data to fuel growth, I’m always looking for the next challenge—optimizing operations, exploring new markets, or designing innovative solutions.

I am a Bioinformatician with extensive experience of analyzing Genomics and Transcriptomics data from Next Generation Sequencing Platforms. I enjoy designing, implementing and automating computational pipelines for Biological Data Analysis using multiple programming languages. I also possess over three years of experience working in wet lab with several Molecular Biology tools. I have worked as teaching assistant for both undergrads and grad students.I enjoy solving problems independently as well as by being part of a collaborative inter-disciplinary team.

Richard Shoemake is the founder and editor of New Online Products, where he covers supplements, skincare, and evidence-based health. With a background in AI architecture and over two decades in technology, he brings a data-driven, research-first approach to wellness content — cutting through marketing hype to focus on what the science actually says. A lifelong learner and self-described health optimizer, Richard follows a ketogenic diet and has spent years researching supplements for longevity, cognitive performance, and overall vitality. His writing is informed by real clinical studies, not trends, and he's committed to making complex health topics accessible to everyday readers. When he's not deep in PubMed or building AI systems, Richard can be found caring for family in the Houston area, including his 86-year-old mother and a 16-year-old cat who has her own opinions about supplement timing. Areas of Expertise: Dietary supplements, longevity science, ketogenic nutrition, skincare ingredients, peptide research, AI & technology

Jodee Gibson, PCC, PhD(c) is an award-winning author, human development researcher, and founder of Human Behavior Architects™. Her work challenges the prevailing mental health narrative by arguing that many behaviors currently labeled as disorders are often the predictable output of developmental gaps within systems never designed to support human development. With more than three decades of experience working with schools, healthcare organizations, and leadership teams, Dr. Gibson operates at the intersection of neuroscience, mental health, developmental psychology, and systems design. Her work focuses on upstream trauma prevention and behavioral system redesign vs trauma-informed care. She helps organizations move beyond symptom management toward environments that support emotional development and sustainable human development. She frequently speaks on healing mental health, understanding behavioral health systems, leadership, and psychology. She is also well versed in the hidden developmental forces shaping human behavior and why many approaches to mental health are addressing the wrong problem.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Dr. Jagdish Khubchandani is a Professor of Public Health at New Mexico State University (NMSU), known for his extensive research and expertise in global health and social epidemiology

Dr. Boluwatife OLU Afolabi is a dental surgeon and PhD candidate in Oral Biology at the University of Minnesota School of Dentistry. His research focuses on the molecular mechanisms driving head and neck squamous cell carcinoma, particularly the role of environmental carcinogens, inflammatory signaling, and transcriptional regulation in disease initiation and progression. His work investigates pathways such as the Aryl Hydrocarbon Receptor (AHR) and S100A8/S100A9-mediated inflammatory responses using cellular and molecular models of oral epithelial transformation. He has extensive experience in cancer biology, oral pathology, toxicology, and translational biomedical research. Dr. Afolabi provides expert insight on oral cancer risk factors, environmental exposures and health, inflammation and disease mechanisms, dental-systemic health connections, and emerging directions in cancer research. He is also interested in public health implications of carcinogen exposure and prevention strategies in oral and head-and-neck disease.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Biomedical scientist, technical writer, and program leader with 15+ years of experience. Founder and principal consultant of BioRipplet Endeavors LLC. Specializes in translating complex biomedical and animal health research into clear, actionable strategies and regulatory, grant, and educational documents. Advanced innovation pipelines, expanded commercial portfolios, produced peer-reviewed publications, multiple grant awards, and coordinated multi-disciplinary teams to deliver high-quality science on schedule and within budget.

Dr. Paul Durham is distinguished professor of biology and director of Missouri State University's Center for Biomedical and Life Sciences, a multidisciplinary laboratory that utilizes cellular/molecular, microbiological, biochemical and chemical techniques. A primary goal of his research is to determine the signaling pathways by which inflammatory and anti-inflammatory agents control neuropeptide gene expression in disorders involving the trigeminal nerve. Currently, he is studying the regulation of protein expression in cultured nerve and glial cells, human cell lines, in vivo animal models and clinical studies. A major focus of his research has been to elucidate the cellular/molecular mechanisms by which novel drugs and nutraceuticals modulate the excitability state of neurons and glial cells under pathological conditions in models of migraine, TMJ disorder and epilepsy. More recently, his laboratory has been investigating epigenetic mechanisms and changes in gut microbiota in response to changes in diet, sleep pattern, stress and chronic inflammation. Durham is frequently invited as a guest lecturer. He has authored or co-authored 80 peer-reviewed research publications, numerous book chapters and technical reports, and 160 published abstracts. He has received nearly $14 million in external grants to support his research. In addition, Durham has served on numerous National Institutes of Health (NIH) study sections and advisory boards, and is currently a reviewer for 15 different journals.

I’m an entrepreneur working at the intersection of AI, product execution, and healthcare access. Over the last decade I’ve built and led teams that turn new technology into practical tools for real businesses. I co-founded BotsCrew in 2016, grew it into a global AI services company, and later joined the CourtAvenue collective, where we help large enterprises adopt generative AI with speed and precision. I also founded AllClinicalTrials.com and Curify, two platforms focused on making it easier for patients to find and enroll in legitimate clinical trials. That work started from a personal experience trying to find treatment options for a family member, and it pushed me toward building products that remove friction from complex systems. My background is in applied mathematics and AI, but most of my learning came from building things fast, talking to customers, and fixing what didn’t work. I’m especially interested in how generative AI will reshape operations, customer experience, and decision-making in large organizations. I try to share what I learn - both the wins and the mistakes - so others can move faster.